Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
37.80
-1.40 (-3.57%)
Feb 17, 2026, 9:30 AM EST

TKPHF Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
59,73545,07443,39950,86944,66256,329
Market Cap Growth
46.07%3.86%-14.68%13.90%-20.71%17.61%
Enterprise Value
90,77678,05075,91881,75574,56398,218
Last Close Price
37.8030.0226.5630.5727.4934.13
PE Ratio
82.9462.5445.5721.3323.5716.57
PS Ratio
2.101.471.541.681.521.95
PB Ratio
1.230.970.901.060.951.20
P/FCF Ratio
9.277.8812.148.085.426.92
P/OCF Ratio
7.886.399.166.924.836.16
EV/Sales Ratio
3.122.552.692.702.543.40
EV/EBITDA Ratio
10.559.4810.048.467.6511.04
EV/EBIT Ratio
23.2220.7622.9917.5415.0925.62
EV/FCF Ratio
14.0813.6521.2312.999.0612.07
Debt / Equity Ratio
0.710.730.750.770.850.98
Debt / EBITDA Ratio
4.093.964.573.794.075.16
Debt / FCF Ratio
5.375.9410.105.814.815.64
Net Debt / Equity Ratio
0.620.680.690.680.700.79
Net Debt / EBITDA Ratio
3.743.814.383.373.354.17
Net Debt / FCF Ratio
4.725.499.255.173.964.56
Asset Turnover
0.290.310.290.300.270.25
Inventory Turnover
1.161.301.301.361.401.34
Quick Ratio
0.540.440.500.490.731.00
Current Ratio
1.191.011.110.971.211.53
Return on Equity (ROE)
1.50%1.52%2.12%5.27%4.24%7.60%
Return on Assets (ROA)
2.47%2.40%2.15%2.85%2.88%2.06%
Return on Invested Capital (ROIC)
2.76%2.91%4.35%5.15%4.82%4.50%
Return on Capital Employed (ROCE)
4.70%4.80%3.90%5.40%5.40%3.80%
Earnings Yield
1.21%1.60%2.20%4.69%4.24%6.04%
FCF Yield
10.79%12.69%8.24%12.37%18.44%14.44%
Dividend Yield
3.50%4.36%4.68%4.43%5.39%4.77%
Payout Ratio
277.04%280.28%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-0.25%-1.58%-0.67%0.46%-0.23%-0.47%
Total Shareholder Return
3.25%2.78%4.01%4.89%5.16%4.30%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.